ACR 3.08% 6.3¢ acrux limited

great buy on evamist news

  1. 461 Posts.
    wilson htm have come out with a report on acrux saying that evamist has been the second best launch of a transdermal product in america.currently new prescription rate of 750 per week.they have put a twelve months target of $2.27.this looks good for the company to sell evamist and other products around the world
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
(20min delay)
Last
6.3¢
Change
-0.002(3.08%)
Mkt cap ! $18.31M
Open High Low Value Volume
6.6¢ 6.6¢ 6.3¢ $5.23K 80.08K

Buyers (Bids)

No. Vol. Price($)
2 249878 6.3¢
 

Sellers (Offers)

Price($) Vol. No.
6.5¢ 73455 1
View Market Depth
Last trade - 15.55pm 05/07/2024 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.